Search research articles
Contact Us
Filters
Showing results (391-400 of 522) with videos related to
Page
of 53
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 30, 2012
Phase I study of humanized monoclonal antibody AVE1642 directed against the type 1 insulin-like growth factor receptor (IGF-1R), administered in combination with anticancer therapies to patients with advanced solid tumors
V M Macaulay, M R Middleton, A S Protheroe, et al.
Cancer Chemotherapy and Pharmacology
|
February 21, 2013
A phase II study of the potent PARP inhibitor, Rucaparib (PF-01367338, AG014699), with temozolomide in patients with metastatic melanoma demonstrating evidence of chemopotentiation
Ruth Plummer, Paul Lorigan, Neil Steven, et al.
The British Journal of Dermatology
|
July 17, 2013
Treatment patterns, outcomes, and resource utilization of patients with metastatic melanoma in the U.K.: the MELODY study
P Lorigan, M Marples, M Harries, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
October 6, 2017
Pseudocyclic Arylbenziodoxaboroles: Efficient Benzyne Precursors Triggered by Water at Room Temperature
Akira Yoshimura, Jonathan M Fuchs, Kyle R Middleton, et al.
Radiology Case Reports
|
September 28, 2018
Long-term radiological and histological outcomes following selective internal radiation therapy to liver metastases from breast cancer
Paul C Lyon, Helen Winter, Karin Herbschleb, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 14, 2010
Tumor O(6)-methylguanine-DNA methyltransferase inactivation by oral lomeguatrib
Amanda J Watson, Ami Sabharwal, Mary Thorncroft, et al.
British Journal of Cancer
|
May 19, 2011
Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer
O A Khan, A D Blann, M J Payne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 3, 2016
Phase I Dose-Escalation Study of Linsitinib (OSI-906) and Erlotinib in Patients with Advanced Solid Tumors
Valentine M Macaulay, Mark R Middleton, S Gail Eckhardt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 11, 2003
Adjuvant interferon in high-risk melanoma: the AIM HIGH Study--United Kingdom Coordinating Committee on Cancer Research randomized study of adjuvant low-dose extended-duration interferon Alfa-2a in high-risk resected malignant melanoma
B W Hancock, K Wheatley, S Harris, et al.
Frontiers in Oncology
|
May 21, 2016
Durable Response of Spinal Chordoma to Combined Inhibition of IGF-1R and EGFR
Tamara Aleksic, Lisa Browning, Martha Woodward, et al.
Page
of 53
Search research articles
Search
Showing results (391-400 of 522) with videos related to
Sort By:
Page
of 53
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 30, 2012
Phase I study of humanized monoclonal antibody AVE1642 directed against the type 1 insulin-like growth factor receptor (IGF-1R), administered in combination with anticancer therapies to patients with advanced solid tumors
V M Macaulay, M R Middleton, A S Protheroe, et al.
Cancer Chemotherapy and Pharmacology
|
February 21, 2013
A phase II study of the potent PARP inhibitor, Rucaparib (PF-01367338, AG014699), with temozolomide in patients with metastatic melanoma demonstrating evidence of chemopotentiation
Ruth Plummer, Paul Lorigan, Neil Steven, et al.
The British Journal of Dermatology
|
July 17, 2013
Treatment patterns, outcomes, and resource utilization of patients with metastatic melanoma in the U.K.: the MELODY study
P Lorigan, M Marples, M Harries, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
October 6, 2017
Pseudocyclic Arylbenziodoxaboroles: Efficient Benzyne Precursors Triggered by Water at Room Temperature
Akira Yoshimura, Jonathan M Fuchs, Kyle R Middleton, et al.
Radiology Case Reports
|
September 28, 2018
Long-term radiological and histological outcomes following selective internal radiation therapy to liver metastases from breast cancer
Paul C Lyon, Helen Winter, Karin Herbschleb, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 14, 2010
Tumor O(6)-methylguanine-DNA methyltransferase inactivation by oral lomeguatrib
Amanda J Watson, Ami Sabharwal, Mary Thorncroft, et al.
British Journal of Cancer
|
May 19, 2011
Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer
O A Khan, A D Blann, M J Payne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 3, 2016
Phase I Dose-Escalation Study of Linsitinib (OSI-906) and Erlotinib in Patients with Advanced Solid Tumors
Valentine M Macaulay, Mark R Middleton, S Gail Eckhardt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 11, 2003
Adjuvant interferon in high-risk melanoma: the AIM HIGH Study--United Kingdom Coordinating Committee on Cancer Research randomized study of adjuvant low-dose extended-duration interferon Alfa-2a in high-risk resected malignant melanoma
B W Hancock, K Wheatley, S Harris, et al.
Frontiers in Oncology
|
May 21, 2016
Durable Response of Spinal Chordoma to Combined Inhibition of IGF-1R and EGFR
Tamara Aleksic, Lisa Browning, Martha Woodward, et al.
Page
of 53